REQUEST A DEMO
Total
USD $0.00
Search more companies

Vartika Chemicals & Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Vartika Chemicals & Pharmaceuticals Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Vartika Chemicals & Pharmaceuticals Private Limited is an unlisted company, incorporated on 21/07/2004. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24232DL2004PTC127743 and registration number is 127743.

Legal Address
Flat No-303, A-89 N 89 Hemkunt Chamberno Internal Road Nehru Place, Near Modi Tower
South Delhi; Delhi; Postal Code: 110019

Contact Details: Purchase the Vartika Chemicals & Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Vartika Chemicals & Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Vartika Chemicals & Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
July 21, 2004
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
96.99%
Purchase this report to view the information.
1.5%
Company Performance
Financial values in the chart are available after Vartika Chemicals & Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
95.04%
Total operating revenue
95.08%
Operating profit (EBIT)
633.55%
EBITDA
283.33%
Net Profit (Loss) for the Period
742.89%
Total assets
50.94%
Total equity
14.44%
Operating Profit Margin (ROS)
2.37%
Net Profit Margin
1.85%
Return on Equity (ROE)
10.91%
Debt to Equity Ratio
72.98%
Quick Ratio
0.01%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?